The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes.
Ontology highlight
ABSTRACT: Type 1 diabetes (T1D) results from progressive loss of pancreatic islet mass through autoimmunity targeted at a diverse, yet limited, series of molecules that are expressed in the pancreatic beta cell. Identification of these molecular targets provides insight into the pathogenic process, diagnostic assays, and potential therapeutic agents. Autoantigen candidates were identified from microarray expression profiling of human and rodent pancreas and islet cells and screened with radioimmunoprecipitation assays using new-onset T1D and prediabetic sera. A high-ranking candidate, the zinc transporter ZnT8 (Slc30A8), was targeted by autoantibodies in 60-80% of new-onset T1D compared with <2% of controls and <3% type 2 diabetic and in up to 30% of patients with other autoimmune disorders with a T
SUBMITTER: Wenzlau JM
PROVIDER: S-EPMC2040407 | biostudies-literature | 2007 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA